Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-004 phase II trial in mild to moderate active ulcerative colitis
2007-005166-12Phase 2Terminated
- Sponsor
- HUTCHMED
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of andrographolide in autoimmune colitis, sponsored by HUTCHMED. Started Jan 2008; status: terminated.
02
Drugs
andrographolide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-005166-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005166-12.